We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-3.03%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$8.84B
AUM Growth
-$870M
Cap. Flow
-$334M
Cap. Flow %
-3.78%
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68

Top Buys

Rank Stock Value
1
KD icon
Kyndryl
KD
+$22.1M
2
CRI icon
Carter's
CRI
+$21.6M
3
ENOV icon
Enovis
ENOV
+$19.7M
4
M icon
Macy's
M
+$18.4M
5
SPNS
Sapiens International
SPNS
+$18.3M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$48.8M
2
SPB icon
Spectrum Brands
SPB
+$27.6M
3
HUN icon
Huntsman Corp
HUN
+$22.1M
4
EAF icon
GrafTech
EAF
+$17.5M
5
VNT icon
Vontier
VNT
+$17.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.25%
2 Technology 17.95%
3 Consumer Discretionary 13.92%
4 Financials 13.49%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCH
876
Dauch Corp
DCH
$1.31B
$257K ﹤0.01%
37,602
-78,895
-68% -$711K
AOUT icon
877
American Outdoor Brands
AOUT
$158M
$254K ﹤0.01%
+28,938
New +$246K
PDCE
878
DELISTED
PDC Energy, Inc.
PDCE
$233K ﹤0.01%
4,035
-122,726
-97% -$7.53M
VNDA icon
879
Vanda Pharmaceuticals
VNDA
$304M
$229K ﹤0.01%
23,155
-52,908
-70% -$559K
SPB icon
880
Spectrum Brands
SPB
$2.03B
$222K ﹤0.01%
5,694
-427,431
-99% -$27.6M
AVPT icon
881
AvePoint
AVPT
$2.76B
$221K ﹤0.01%
+55,000
New +$259K
GD icon
882
General Dynamics
GD
$103B
$212K ﹤0.01%
1,000
-8,500
-89% -$1.92M
UFAB
883
DELISTED
Unique Fabricating, Inc.
UFAB
$212K ﹤0.01%
404,796
-118,085
-23% -$111K
CPK icon
884
Chesapeake Utilities
CPK
$3.28B
$203K ﹤0.01%
1,760
-4,245
-71% -$550K
PAAS icon
885
Pan American Silver
PAAS
$17.9B
$202K ﹤0.01%
12,700
– –
HNI icon
886
HNI Corp
HNI
$3.08B
$201K ﹤0.01%
7,580
-17,225
-69% -$571K
AAOI icon
887
Applied Optoelectronics
AAOI
$6.14B
$195K ﹤0.01%
+71,852
New +$162K
OSUR icon
888
OraSure Technologies
OSUR
$273M
$189K ﹤0.01%
50,000
– –
TRHC
889
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$184K ﹤0.01%
38,400
– –
PETQ
890
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$173K ﹤0.01%
25,000
– –
CGAU
891
Centerra Gold
CGAU
$3.38B
$172K ﹤0.01%
39,000
– –
HA
892
DELISTED
Hawaiian Holdings, Inc.
HA
$166K ﹤0.01%
12,644
-11,948
-49% -$182K
GNW icon
893
Genworth Financial
GNW
$3.86B
$157K ﹤0.01%
44,751
+7,280
+19% +$29.4K
TACT icon
894
Transact Technologies
TACT
$50.5M
$149K ﹤0.01%
40,900
– –
ZVO
895
DELISTED
Zovio Inc. Common Stock
ZVO
$142K ﹤0.01%
996,264
-1,571,212
-61% -$777K
SIF icon
896
SIFCO Industries
SIF
$167M
$141K ﹤0.01%
45,800
– –
CANO.WS
897
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$132K ﹤0.01%
49,999
– –
HALL
898
DELISTED
Hallmark Financial Services, Inc.
HALL
$120K ﹤0.01%
11,400
– –
SQNS
899
Sequans Communications SA
SQNS
$37.4M
$114K ﹤0.01%
1,272
– –
GAN
900
DELISTED
GAN Ltd
GAN
$99K ﹤0.01%
44,700
– –
34 35
36
37 38

Similar funds

GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $9.98B AUM 4.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Royce & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Royce & Associates held 997 positions worth $8.84B, down 9% from $9.71B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates withdrew a net $334M in Q3 2022, closing 68 positions and reducing 362 holdings. Its most notable exit was Avalara, Inc., an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Kyndryl worth $17.6M.

  • Royce & Associates's largest Q3 2022 buy was Kyndryl: 2,126,158 shares worth $17.6M.
  • Royce & Associates added most to Carter's in Q3 2022, an estimated $21.6M increase.
  • Royce & Associates's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $48.8M.
  • Royce & Associates fully exited Avalara, Inc. in Q3 2022, selling an estimated $17.4M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $8.84B portfolio in Q3 2022.
  • Royce & Associates opened 62 new positions and closed 68 in Q3 2022.
  • Royce & Associates's portfolio value fell 9% quarter-over-quarter to $8.84B.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.